Top updates from ASCO GU 2026: latest trials in prostate, kidney, and bladder cancer
About this episode
The episode discusses the latest advancements in genitourinary cancers presented at ASCO GU 2026.
In this week’s VJOncology podcast, we will be covering highlights from ASCO GU 2026 in San Francisco, CA. Dive into the latest advancements in genitourinary cancers, including groundbreaking trial results and emerging treatment strategies. In this episode, join Enrique Gallardo, MD, Parc Taulí University Hospital, Barcelona, Spain, Jan-Jaap Mellema, MD, Netherlands Cancer Institute, Amsterdam, The Netherlands, Pooja Ghatalia, MD, Fox Chase Cancer Center, Philadelphia, PA, Joaquim Bellmunt, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, and, Aly-Khan Lalani, MD, McMaster University, Hamilton, Canada, as they discuss critical findings from ASCO GU 2026, including combination therapies, innovative approaches to bladder preservation, and novel biomarkers in prostate and renal cell carcinoma.
More episodes of VJOncology Podcast
- Bladder Cancer Awareness Month: subtypes, diagnostics & breakthroughs
- Beyond EGFR: navigating molecular targets and emerging therapies in advanced NSCLC
- Head and neck cancer awareness month: key trials and evolving treatment strategies
- Lung cancer highlights from the 24th BTOG annual conference
- Immuno-oncology updates from 12th Immunotherapy of Cancer Conference
- Esophageal cancer awareness month: from multidisciplinary dialogue to clinical impact
Explore listener stats, chart rankings, contacts and more on the VJOncology Podcast podcast page.